Calidi Biotherapeutics (CLDI) Appoints George Peoples to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. ORCL
7. USO
8. STZ
9. CRGY
10. AAPL

Go back to Calidi Biotherapeutics (CLDI) Appoints George Peoples to its Board

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

June 27, 2024 7:00 AM EDT

SAN DIEGO--(BUSINESS WIRE)-- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or Calidi), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the appointment of Dr. George E. Peoples, MD, FACS, to the companys Board of Directors, effective July 1, 2024.

Dr. Peoples is a highly esteemed figure in the field of cancer immunotherapy, bringing decades of experience in cancer vaccine development and clinical research to our Board, said Allan Camaisa, CEO and Chairman of the Board of Calidi Biotherapeutics. Dr. Peoples pioneering work in cancer immunotherapy and his extensive experience in both clinical and military settings... More